Predictors of short-term disease activity following a first clinical demyelinating event: analysis of the CHAMPS placebo group

We evaluated 190 patients in the placebo group of the CHAMPS trial in order to assess factors associated with short-term dinical and brain magnetic resonance imaging (MRI) outcomes in patients with a first dinical demyelinating event involving the optic nerve, spinal cord, or brainstem/cerebellum, a...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Multiple sclerosis 2002-10, Vol.8 (5), p.405-409
1. Verfasser:	CHAMPS Study Group
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Biological and medical sciences Brain - pathology Cohort Studies Controlled Clinical Trials as Topic Demyelinating Diseases - complications Demyelinating Diseases - drug therapy Demyelinating Diseases - physiopathology Female Humans Magnetic Resonance Imaging Male Medical sciences Multicenter Studies as Topic Multiple Sclerosis - diagnosis Multiple Sclerosis - etiology Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis Neurology Prognosis Time Factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!